- NCIt
- C8101
Loading cancer entity…
Loading cancer entity…
Clinical trials
1,164 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00734890 | Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | 18 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 16, 2012 | clinicaltrials |
| NCT00019019 | Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas | completed | Phase 1 | 70 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 |
| clinicaltrials |
| NCT00031941 | CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy | completed | Phase 1 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00088868 | 17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma | completed | Phase 1 | 40 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00095914 | Paclitaxel and ABI-007 in Treating Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00356980 | TNF-Bound Colloidal Gold in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 60 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00387608 | ABT-888 in Patients With Refractory Solid Tumors or Hematologic Cancer | completed | Phase 1 | 23 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00021047 | Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor | completed | Phase 1 / Phase 2 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00062049 | Interleukin-7 in Treating Patients With Refractory Solid Tumors | completed | Phase 1 | 30 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00589381 | Fenretinide Lym-X-Sorb™ in Treating Patients With Recurrent or Resistant Solid Tumors or Lymphoma | completed | Phase 1 | 30 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00520000 | Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | 47 | UNC Lineberger Comprehensive Cancer CenterOTHER | 0 | Mar 6, 2012 | clinicaltrials |
| NCT01028859 | Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers | completed | Phase 1 | 30 | Chong Kun Dang PharmaceuticalINDUSTRY | 1 | Dec 22, 2011 | clinicaltrials |
| NCT00003038 | Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Mayo ClinicOTHER | 1 | Aug 3, 2011 | clinicaltrials |
| NCT00003690 | Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 48 | Mayo ClinicOTHER | 1 | Aug 3, 2011 | clinicaltrials |
| NCT00004075 | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery | completed | Phase 1 | — | Mayo ClinicOTHER | 1 | Aug 3, 2011 | clinicaltrials |
| NCT00005068 | Combination Chemotherapy In Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | — | Mayo ClinicOTHER | 1 | Aug 3, 2011 | clinicaltrials |
| NCT00006362 | PS-341 in Treating Patients With Advanced Cancer | completed | Phase 1 | — | Mayo ClinicOTHER | 1 | Aug 3, 2011 | clinicaltrials |
| NCT00401180 | Docetaxel and Temozolomide in Treating Patients With Metastatic Cancer | completed | Phase 1 | 25 | The Cleveland ClinicOTHER | 1 | Jul 8, 2011 | clinicaltrials |
| NCT00415116 | Lenalidomide, Docetaxel, and Carboplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 14 | The Cleveland ClinicOTHER | 0 | Jul 8, 2011 | clinicaltrials |
| NCT00616213 | PR104 and G-CSF in Treating Patients With Solid Tumors | completed | Phase 1 | 5 | Proacta, IncorporatedINDUSTRY | 2 | Jun 1, 2011 | clinicaltrials |
| NCT01358227 | A Phase I Dose Escalation Trial of PR104 Given Weekly in Subjects With Solid Tumors | completed | Phase 1 | 26 | Proacta, IncorporatedINDUSTRY | 1 | May 24, 2011 | clinicaltrials |
| NCT00667641 | Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | completed | Phase 1 | 16 | University of Medicine and Dentistry of New JerseyOTHER | 1 | May 10, 2011 | clinicaltrials |
| NCT00003144 | Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors | completed | Phase 1 | 44 | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00003331 | Combination Chemotherapy in Treating Patients With Advanced Cancer | completed | Phase 1 | 30 | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00004105 | Combination Chemotherapy in Treating Patients With Advanced Cancer | completed | Phase 1 / Phase 2 | — | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00004030 | VX-853 in Treating Patients With Solid Tumors Who Are Receiving Liposomal Doxorubicin | completed | Phase 1 / Phase 2 | 45 | Georgetown UniversityOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00020748 | Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer | completed | Phase 1 | — | Georgetown UniversityOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00003294 | Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer | completed | Phase 1 | 24 | Roswell Park Cancer InstituteOTHER | 1 | Mar 7, 2011 | clinicaltrials |
| NCT00003882 | Anhydrovinblastine in Treating Patients With Advanced Recurrent Solid Tumors | completed | Phase 1 | 10 | Roswell Park Cancer InstituteOTHER | 1 | Mar 7, 2011 | clinicaltrials |
| NCT00024141 | Irinotecan Followed by Fluorouracil in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Roswell Park Cancer InstituteOTHER | 1 | Mar 7, 2011 | clinicaltrials |
| NCT00033566 | S-3304 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Roswell Park Cancer InstituteOTHER | 1 | Mar 7, 2011 | clinicaltrials |
| NCT00459836 | PR-104 and Docetaxel or Gemcitabine in Treating Patients With Solid Tumors | completed | Phase 1 | 42 | Proacta, IncorporatedINDUSTRY | 2 | Mar 2, 2011 | clinicaltrials |
| NCT00646139 | KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment | completed | Phase 1 | 7 | Roswell Park Cancer InstituteOTHER | 1 | Mar 2, 2011 | clinicaltrials |
| NCT00006086 | BMS-188797 and Carboplatin in Treating Patients With Advanced Nonhematologic Cancer | completed | Phase 1 | — | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 9, 2010 | clinicaltrials |
| NCT00002915 | Penclomedine in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT00003289 | UCN-01 in Treating Patients With Advanced Cancer | completed | Phase 1 | — | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT00047242 | UCN-01 and Irinotecan in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 30 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT00368914 | Sirolimus in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 30 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT00002604 | O(6)-Benzylguanine and Carmustine in Treating Patients With Solid Tumors | completed | Phase 1 | 28 | Case Comprehensive Cancer CenterOTHER | 1 | Jul 8, 2010 | clinicaltrials |
| NCT00388089 | Bortezomib and Topotecan in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 24 | University of California, DavisOTHER | 1 | Jun 29, 2010 | clinicaltrials |
| NCT00005642 | SU5416 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 19 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00005819 | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 21 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00006018 | Paclitaxel and BMS-214662 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 5 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00006372 | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 10 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00006465 | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 22 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00253344 | Lenalidomide and Docetaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 33 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00376727 | Cetuximab in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 27 | University of California, DavisOTHER | 1 | Mar 29, 2010 | clinicaltrials |
| NCT00387322 | Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors | completed | Phase 1 / Phase 2 | 42 | University of California, DavisOTHER | 1 | Mar 29, 2010 | clinicaltrials |
| NCT00003082 | Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer | completed | Phase 1 | 27 | University of ArizonaOTHER | 1 | Mar 16, 2010 | clinicaltrials |
| NCT00084513 | Trastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2/Neu-Expressing Cancer | completed | Phase 1 | 18 | Fox Chase Cancer CenterOTHER | 1 | Feb 12, 2010 | clinicaltrials |
Data updated 23 days agoSource updated Mar 16, 2012source: clinicaltrials